Iperia HF-T Completes BIOTRONIK's US Portfolio Of MR Conditional Tachycardia Devices

BIOTRONIK, a leader in cardio- and endovascular medical technology, recently announced Food and Drug Administration (FDA) approval of Iperia ProMRI HF-T, a cardiac resynchronization defibrillator that provides heart failure patients with access to diagnostic magnetic resonance imaging (MRI) scans.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news